Fairvalue-Calculator Fairvalue-Calculator
EN DE

Norbel Baby Co (6844) Fair Value & Analysis

Consumer Cyclical · TW · Market cap 2.5B TWD

Price65.40 TWD
Fair Value46.94 TWD
Upside-28.2%
Quality95/100
Evidence: High Range 35.21 TWD – 58.68 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Norbel Baby Co (6844) currently trades at 65.40 TWD, while our model-based Fair Value estimate is 46.94 TWD — implying the stock looks roughly 28.2% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Norbel Baby Co., Ltd engages in the sale of medicine, medical care, health care, maternity and baby care, and beauty care products in Taiwan. The company operates chain retail stores of cosmetics and pharmacy under the brand "Tin Tin Drugstore". It also provides consulting services. The company was founded in 1986 and is headquartered in Kaohsiung, Taiwan.

Open the full interactive analysis →

Similar stocks

Alimentation Couche-Tard Inc (ANCTF) +7% Casey's General Stores, Inc (CASY) -71% Williams-Sonoma, Inc (WSM) -27% Ulta Beauty, Inc (U1LT34) -78% DICK'S Sporting Goods, Inc (DKS) +44% China Tourism Group (601888) -15%

Frequently asked questions

Is Norbel Baby Co (6844) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 46.94 TWD versus a price of 65.40 TWD — about −28% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6844?
Our 21-model fair value for Norbel Baby Co is 46.94 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 65.40 TWD.
What is the quality score of 6844?
Norbel Baby Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.